More on REGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $656.01 |
|
|||
| Open | $661.77 | ||||
| 52 Wk High | $592.36 | ||||
| 52 Wk Low | $325.35 | ||||
| Day High | $678.12 | ||||
| Day Low | $659.53 | ||||
| P/E | 175.11 | ||||
| EPS | $3.81 | ||||
| Volume | 650,873 | ||||
- Tessera Therapeutics names former Merck executive as new CEO
- Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
- Regeneron Pharma (REGN) PT Raised to $1,000 at Guggenheim
- Regeneron Pharma (REGN) Reiterated at Overweight by Cantor Fitzgerald
- Regeneron Pharma (REGN) PT Lowered to $854 at Piper Sandler
- Regeneron Pharma (REGN) PT Lowered to $730 at Morgan Stanley
- Form 4 REGENERON PHARMACEUTICAL For: Jul 02 Filed by: RYAN ARTHUR F
- Regeneron Pharma (REGN) PT Lowered to $696 at RBC Capital
- Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
- Form 8-K REGENERON PHARMACEUTICAL For: Jul 06
Entities mentioned with REGN
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
